Callan Family Office »

Relay Therapeutics shares owned by Callan Family Office

Quarter-by-quarter ownership of Relay Therapeutics (RLAY) shares owned by Callan Family Office from 13F filings

Historical chart of Callan Family Office investment in Relay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relay Therapeutics held by Callan Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relay Therapeutics by Callan Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $174k 21k 8.46

More positions owned by Callan Family Office

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Vanguard Scottsdale Fds Vng Rus3000idx (VTHR)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Ishares Tr Rus 1000 Grw Etf (IWF)
Visa Com Cl A (V)

View all positions for Callan Family Office

Top funds holding Relay Therapeutics

Sb Investment Advisers
Commodore Capital
Point72 Asset Management
BlackRock
Casdin Capital
Vanguard Group
Bellevue Group
State Street Corporation
Nextech Invest
Geode Capital Management
TCG Crossover Management
Dimensional Fund Advisors
MPM Oncology Impact Management
Goldman Sachs Group
Balyasny Asset Management

View all funds holding Relay Therapeutics